Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
Journal: Human gene therapy
Published: September 12, 2022
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 19, 2020
Engineering universal cells that evade immune detection.
Journal: Nature reviews. Immunology
Published: July 08, 2019
Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.
Journal: JCI insight
Published: May 01, 2019
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Journal: Journal of virology
Published: September 18, 2017
Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 24, 2017
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Journal: Nature biotechnology
Published: May 09, 2016
Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.
Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2015
Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 20, 2015
Last Updated: 09/26/2026